Odysight.ai Inc Dossier - Source-backed chat

Odysight.ai Inc

ODYSNASDAQ

SectorInformation Technology

IndustryElectronic Equipment & Instruments

Beta (adjusted)1.00

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $2.82Price as of 1 Oct 2026

Data confidenceNot applicable

Market Cap $47.4M

Enterprise Value $21.7M

Shares Outstanding 16.8M diluted

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Odysight.ai Inc. (NASDAQ/TASE: ODYS) is a pioneer in AI-driven visual sensing and predictive maintenance (PdM) solutions, targeting high-barrier-to-entry sectors such as aerospace, defense, and heavy industry. While the company is currently in a high-investment, pre-profitability phase—characterized by a decline in legacy medical revenues and widening operating losses—its core vision-based PdM/CBM platform grew 23% year-over-year in FY2025. Backed by a robust $13.8 million backlog, successful test flights on UH-60 Black Hawk helicopters, a CRADA with the U.S. Navy, and a recent proof-of-concept order from Honeywell Aerospace, Odysight.ai is successfully validating its technology with tier-1 partners. The company's dual listing on the Tel Aviv Stock Exchange and its strong net cash position of $21.8 million (with no debt) provide a solid foundation to execute its commercialization strategy.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets1 analysts · as of 18 Aug 2026

Low · most bearish analyst$6.00

Mean target$6.00

High · most bullish analyst$6.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$3.5015%

Geopolitical instability in Israel severely disrupts R&D and operations, leading to prolonged delays in product delivery. Slow customer adoption cycles in risk-averse industrial and defense markets stall revenue growth, forcing highly dilutive capital raises under the ATM program as cash reserves dwindle.

Base CaseCentral scenario

$10.0060%

Steady monetization of the backlog and gradual expansion of pilot programs into multi-year production contracts. The company maintains its cash runway through disciplined spending and opportunistic use of its ATM program, aligning with the consensus Wall Street target of $10.00 as commercial validation continues.

Bull CaseUpside scenario

$10.5025%

Rapid conversion of the $13.8 million backlog combined with large-scale commercial rollouts from pilot programs (e.g., Honeywell Aerospace, U.S. Navy, and European elevator belt monitoring) drives exponential revenue growth. Operating leverage kicks in as software-driven AI models scale, leading to profitability ahead of consensus expectations.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strong commercial validation with tier-1 aerospace and defense partners, including Honeywell, the U.S. Navy, and the Israeli Air Force.
A substantial backlog of $13.8 million providing clear revenue visibility for the upcoming fiscal years.
Robust balance sheet with $21.8 million in cash and cash equivalents and zero debt as of Q1 2026.
High-barrier-to-entry proprietary technology (TruVision platform) combining micro-cameras with specialized edge-AI models for harsh environments.

Key Investment Risks

High customer concentration and long, complex sales cycles typical of the aerospace and defense industries.
Geopolitical and military instability in Israel, where the company's primary R&D and headquarters are located.
Ongoing operating losses ($17.0 million net loss in FY2025) and high cash burn as the company scales operations.
Risk of future equity dilution through the established $20 million At-The-Market (ATM) program.

Thesis Invalidation Triggers

Cancellation or significant delay of key defense contracts (e.g., UH-60 Black Hawk or U.S. Navy CRADA).
Quarterly cash burn accelerating beyond $6 million without corresponding revenue growth.
Failure to convert the Honeywell Aerospace proof-of-concept into a commercial purchase order.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.